Yes — long-term Metformin use reduces Vitamin B12 absorption in 5-40% of patients by blocking calcium-dependent uptake in the terminal ileum, and ADA 2025 recommends periodic B12 monitoring for anyone on long-term Metformin therapy. B12 deficiency from Metformin typically develops slowly over 2-5 years and causes peripheral neuropathy symptoms — tingling and numbness in hands and feet — that are identical to diabetic neuropathy, making it frequently misattributed.
The richest dietary B12 sources are clams, beef liver, sardines, salmon, tuna, beef, eggs, and dairy products — however, because Metformin blocks the absorption mechanism rather than reducing dietary B12, eating more B12-rich foods may not fully overcome the malabsorption. Discuss B12 supplementation with your physician if your levels are declining, as oral high-dose B12 or injections are often more effective than dietary intervention alone for Metformin-induced deficiency.
Measurable B12 decline typically begins around 12 months of Metformin use, with clinical deficiency emerging between 2 and 5 years of continuous use in susceptible patients. Your body stores enough B12 to last 3-5 years even with zero intake, which is why the deficiency develops silently — by the time symptoms appear, stores may already be significantly depleted.
Heavy alcohol use with Metformin raises the risk of lactic acidosis — a rare but potentially fatal condition — and ADA guidelines recommend avoiding excessive alcohol intake on this medication. Occasional moderate drinking is generally considered low risk, but discuss your specific situation with your physician, particularly if you have any kidney or liver concerns.
Long-term Metformin use reduces Vitamin B12 absorption by interfering with calcium-dependent uptake in the gut. Studies show B12 deficiency in 5–40% of long-term Metformin users. B12 deficiency causes neurological symptoms (tingling, numbness, fatigue) that can be mistaken for diabetic neuropathy. Clinical guidelines recommend B12 monitoring for anyone on Metformin for more than 3 years.
If you also take a GLP-1 agonist (Ozempic, Victoza), B12 depletion risk compounds — both medications reduce appetite, which means B12 dietary intake may also fall.